The presenilins as potential drug targets in Alzheimer’s disease

Author： Cupers P. Annaert W.G. Strooper B.D.

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.3, Iss.3, 1999-09, pp. : 413-422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential therapeutic targets for Alzheimer’s disease

By McKeon-O’Malley C. Saunders A.J. Bush A.I. Tanzi R.E.

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 2, 1998-12 ,pp. : 157-179

Informa Healthcare

Access to resources Recommend Favorite

Alzheimer's Disease: Targets For Drug Development

Mini Reviews in Medicinal Chemistry, Vol. 2, Iss. 1, 2002-02 ,pp. : 1-9

Bentham Science Publishers

Access to resources Recommend Favorite

New concepts in the drug therapy of Alzheimer’s disease

By Farlow Martin R Hake Ann Marie

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 12, 2001-12 ,pp. : 1975-1983

Informa Healthcare

Access to resources Recommend Favorite

Secretases as therapeutic targets in Alzheimer’s disease: patents 2000 – 2004

By Larner AJ

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 10, 2004-10 ,pp. : 1403-1420

Informa Healthcare

Access to resources Recommend Favorite

Emerging Targets in Neurodegeneration: New Opportunities for Alzheimer's Disease Treatment?

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 15, 2013-08 ,pp. : 1879-1904

Bentham Science Publishers

Access to resources Recommend Favorite